Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 310 Lymphoma 306 Lymphoma, Non-Hodgkin 227 Lymphoma, Large B-Cell, Diffuse 220 Lymphoma, Follicular 201 Leukemia, Lymphocytic, Chronic, B-Cell 168 Lymphoma, B-Cell 147 Recurrence 124 Burkitt Lymphoma 117 Lymphoma, Mantle-Cell 112 Leukemia, Myeloid, Acute 106 Leukemia 103 Hodgkin Disease 102 Multiple Myeloma 95 Lymphoma, B-Cell, Marginal Zone 87 Neoplasms 80 Myelodysplastic Syndromes 69 Lymphoma, T-Cell, Peripheral 62 Hematologic Neoplasms 61 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58 Lymphoma, T-Cell 52 Lymphoma, T-Cell, Cutaneous 44 Waldenstrom Macroglobulinemia 41 Leukemia, Biphenotypic, Acute 35 Mycosis Fungoides 31 Lymphoproliferative Disorders 30 Leukemia, B-Cell 30 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29 Breast Neoplasms 28 Myeloproliferative Disorders 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Large B-cell Lymphoma × Lymphoid × Clear all

NCT07215585 2026-05-22

SOUNDTRACK-D2

AstraZeneca

Phase 3 Recruiting

Large B-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡